Regular Ivermectin Use May Cut Risk Of Contracting Covid: St
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting COVID-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.

This research is the most comprehensive review of the available data on ivermectin taken from clinical, in vitro, animal, and real-world studies, its authors said. We conducted the most comprehensive review of the available data on ivermectin, said Pierre Kory, president and chief medical officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts, which led the study.

We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic, Pierre Kory said in a statement. Ivermectin is an oral drug that is used as a prescription medication to treat parasitic infections. A focus of the study was on the 27 controlled trials available in January 2021, 15 of which were randomised controlled trials.

The authors found a large, statistically significant reduction in mortality, time to recovery, and viral clearance in COVID-19 patients treated with ivermectin. To evaluate the efficacy of ivermectin in preventing COVID-19, three RCT's and five observational controlled trials including almost 2,500 patients were analysed.

All studies reported that ivermectin significantly reduces the risk of contracting COVID-19 when used regularly, the authors said. Many regions around the world now recognise that ivermectin is powerful prophylaxis and treatment for COVID-19, the researchers said. The results as seen in this latest study demonstrate that the ivermectin distribution campaigns repeatedly led to "rapid population-wide decreases in morbidity and mortality," they said.

Dr. T●●●●z H●●●●●●i and 28 others like this29 shares
M●●●●●●i s●●●●●●a
m●●●●●●i s●●●●●●a General Medicine
Ivermectin 12 mg od for 3 - 5 days
May 12, 2021Like
A●●●t S●●●h
A●●●t S●●●h General Medicine
Which study ? Where are the papers ?
May 12, 2021Like
Dr. V●●●l P●●●l
Dr. V●●●l P●●●l Internal Medicine
We are not seeing any positive results. We have used it extensively for mild n moderate patients. But patients don' t do that well. It' s not a magic bullet by any chance.
May 13, 2021Like2